Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...

From prescription medications that promise life-changing results to vitamin supplements that promote natural wellness, the options are endless — and so are the risks.

Kimberly-Clark is making a big move with a nearly $50 billion acquisition. The North Texas company plans to acquire Kenvue ...

The deal will unite two giants in the over-the-counter health business, bringing together brands like Kleenex and Benadryl.

Kimberly-Clark will acquire Kenvue, the Johnson & Johnson spinoff, in a $48.7B cash and stock deal to create a global consumer health leader.

Not long after President Trump made his statement, Kenvue and Johnson & Johnson got into another complicated legal mess when ...

Kimberly-Clark Corp. will acquire Tylenol maker Kenvue Inc. in a cash and stock deal valued at almost $49 billion the two companies announced Nov. 3.

Kimberly-Clark is laying down $40 billion to buy Kenvue in a massive deal that has puzzled some investors as the Tylenol ...

US consumer goods giant Kimberly-Clark announced Monday a $48.7 billion deal to acquire the major health company Kenvue, ...

What company makes Tylenol? Kimberly-Clark buys Kenvue in massive billion-dollar deal. Here's the who and what to know about ...